Main Content start here
Main Layout
Report Description

Report Description

United Kingdom blood glucose monitoring devices market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The market growth can be attributed to surge in the demand for the technologically advanced monitoring devices. Increasing cases of diabetes and growing geriatric population propel the growth of the United Kingdom blood glucose monitoring devices market in the upcoming five years. Higher prevalence of sedentary lifestyle, unhealthy eating habits, and laid back lifestyle of the younger population has shifted large sections of the population be contracting diabetes thereby growing the demand for the glucose monitoring devices and thus the growth of the United Kingdom blood glucose monitoring devices market in the future five years.

Blood glucose monitoring devices are self-defining medical devices that are used to monitor the irregular concentration of glucose in the blood. Diabetic patients require blood glucose monitoring devices to keep a regular check over their sugar intakes and changing blood sugar level. The patients suffering from type 1 diabetes produce less amount of insulin. Or the insulin being produced by the pancreas in the human body gets attacked by their own immune system thus the digestion of sugar molecule fails. Blood glucose monitoring devices monitor the level of sugar in the blood. The devices can be a self-monitoring device that includes a glucometer to analyze the blood sample, test strips to procure the sample on and to be inserted in the glucometer for the test, and lancets to prick the finger to collect blood sample. The device usually comes with an in-built screen or mobile based applications that displays the sugar level. There are continuous blood glucose monitoring devices too, that are usually worn on body. In certain cases, the sensors are placed under the skin of belly or on the back of arm. A transmitter is attached to the sensor sends information to the wireless monitor usually clipped over the belt.

Growing Disease Burden Drives Market Growth

Increasing instances of diabetes majorly type 2 diabetes is driving the growth of the United Kingdom blood glucose monitoring devices market in the upcoming five years. Increasing geriatric population of the country and genetic evolution leads to increasing instances of type 2 diabetes among the population. As per records, the government predicts with no changes in the lifestyle of the population, the country may account for over 5.5 million population be suffering from diabetes. Over 90% of the population suffers from type 2 diabetes and the female population is highly susceptible to type 2 diabetes about 44.3% and the male population suffers more from type1 diabetes about 56.5% as of 2021.

Furthermore, the patients suffering from diabetes are at high risk of heart failures, heart attacks, and other cardiovascular diseases. The immune system of the patient suffers too, the patient is often at higher risk of contracting infectious disease and severity in various cases might lead to death. Also, during the recent pandemic condition, diabetic patients were at the highest risk. Thus, increasing instances of diabetes is actively influencing the demands and thus the growth of the United Kingdom blood glucose monitoring devices market in the future five years.


Click here to download the sample

Market Segmentation

The United Kingdom blood glucose monitoring devices market is segmented by product type, application, end user, competitional landscape, and regional distribution. Based on product type, the market is bifurcated into self-blood glucose monitoring devices and continuous glucose monitoring devices. Self-blood glucose monitoring devices includes glucometers, test strips, and lancets. Continuous glucose monitoring devices include sensors, transmitters & receivers, and integrated insulin pumps. By application, the market is further segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Based on end user, the market is fragmented into home care settings, hospital, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside.

Company Profile

Abbott Laboratories Limited, Johnson & Johnson Limited, Medtronic UK, Roche Diagnostics Limited, Becton Dickinson U.K. Limited, Nipro Medical UK Limited, Bayer UK Limited, among others is a partial list of major market players of the companies responsible for the growth of United Kingdom blood glucose monitoring devices market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, volume in units, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Product Type

·         Application

·         End User

Regional scope

London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside

Key companies profiled

Abbott Laboratories Limited, Johnson & Johnson Limited, Medtronic UK, Roche Diagnostics Limited, Becton Dickinson U.K. Limited, Nipro Medical UK Limited, Bayer UK Limited

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, United Kingdom blood glucose monitoring devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United Kingdom Blood Glucose Monitoring Devices Market, By Product Type:
    • Self-Blood Glucose Monitoring Devices
      • Glucometers
      • Test Strips
      • Lancets
    • Continuous Glucose Monitoring Devices
      • Sensors
      • Transmitters & Receivers
      • Integrated Insulin Pumps
  • United Kingdom Blood Glucose Monitoring Devices Market, By Application:
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Gestational Diabetes
  • United Kingdom Blood Glucose Monitoring Devices Market, By End User:
    • Home Care Settings
    • Hospital
    • Others
  • United Kingdom Blood Glucose Monitoring Devices Market, By Region:

o   London

o   East Anglia

o   Southwest

o   Southeast

o   Scotland

o   East Midlands

o   Yorkshire & Humberside

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom Blood glucose monitoring devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

United Kingdom Blood Glucose Monitoring Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United Kingdom Blood Glucose Monitoring Devices Market

4.    Executive Summary

5.    Voice of Customer

6.    United Kingdom Blood Glucose Monitoring Devices Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product Type (Self Blood Glucose Monitoring Devices v/s Continuous Glucose Monitoring Devices)

6.2.2.     By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)

6.2.3.     By End User (Home Care Settings, Hospital, Others)

6.2.4.     By Region

6.2.5.     By Company (2021)

6.3.  Product Market Map

7.    United Kingdom Self Blood Glucose Monitoring Devices Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Glucometers, Test Strips, Lancets)

7.2.2.     By Application

7.2.3.     By End User

8.    United Kingdom Continuous Blood Glucose Monitoring Devices Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (Sensors, Transmitters & Receivers, Integrated Insulin Pumps)

8.2.2.     By Application

8.2.3.     By End User

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  Pricing Analysis

13.  Import-Export Analysis

14.  United Kingdom Economic Profile

15.  Competitive Landscape

15.1.              Abbott Laboratories Limited

15.2.              Johnson & Johnson Limited

15.3.              Medtronic UK

15.4.              Roche Diagnostics Limited

15.5.              Becton Dickinson U.K. Limited

15.6.              Nipro Medical UK Limited

15.7.              Bayer UK Limited

16.  Strategic Recommendations

(Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions

Frequently asked questions

United Kingdom blood glucose monitoring devices market is anticipated to grow with an impressive CAGR during the forecast period, 2023-2027, on account of surging demand for better and technologically advanced medical devices efficient in monitoring the glucose levels.

By application, the market is fragmented into type 1, type 2, gestation diabetes. Type 2 diabetes monitoring applications may dominate the market due to increasing patients suffering from type 2 diabetes and their sedentary lifestyles.

Being responsible for the due growth of the market, some of the leading players of the United Kingdom blood glucose monitoring devices market were Abbott Laboratories Limited, Johnson & Johnson Limited, Medtronic UK, Roche Diagnostics Limited, Becton Dickinson U.K. Limited, Nipro Medical UK Limited, Bayer UK Limited, among others.

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

Related Reports